HIF-1α suppresses myeloma progression by targeting Mcl-1

被引:1
|
作者
Wu, Feng [1 ]
Tong, Dong-Dong [2 ]
Ni, Lei [2 ]
Wang, Lu-Min [2 ]
Wang, Meng-Chang [3 ]
机构
[1] Xi An Jiao Tong Univ, Ctr Teaching & Expt Med Post Grad, Sch Med, Xian, Shaanxi, Peoples R China
[2] Xi An Jiao Tong Univ, Sch Basic Med Sci, Dept Cell Biol & Genet, Hlth Sci Ctr, Xian, Shaanxi, Peoples R China
[3] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Hematol, Xian, Shaanxi, Peoples R China
基金
中国国家自然科学基金;
关键词
HIF-1; alpha; Mcl-1; MMs; proliferation; apoptosis; EPITHELIAL-MESENCHYMAL TRANSITION; CANCER; CELLS; PROLIFERATION; APOPTOSIS; PATHWAY; VEGF;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
HIF-1 alpha is involved in the carcinogenesis and progression of multiple types of cancer. However, the precise role of HIF-1 alpha is unclear in multiple myeloma. Through the qRT-PCR and CCK-8 assays, we demonstrated that silenc-ing the expression of HIF-1 alpha and Mcl-1, MM proliferation can be decreased and apoptosis can be induced. Next, using the GEO database, we found that Mcl-1 was increased in MMs. Mcl-1 overexpression counterbalanced the tumor suppressing effect of siHIF-1 alpha on MM apoptosis. Additionally, HIF-1 alpha acting as a transcription factor, could directly target the promoter region of Mcl-1 to promote Mcl-1 expression. Based on the experimental result, our find-ings strongly suggest that HIF-1 alpha regulated the progression of MMs by directly targeting the Mcl-1.
引用
收藏
页码:1483 / +
页数:10
相关论文
共 50 条
  • [41] Targeting HIF-1 using gene therapy
    Cowen, RL
    Williams, KJ
    Brown, LM
    Stratford, IJ
    JOURNAL OF GENE MEDICINE, 2004, 6 (09): : S30 - S30
  • [42] New anticancer strategies targeting HIF-1
    Yeo, EJ
    Chun, YS
    Park, JW
    BIOCHEMICAL PHARMACOLOGY, 2004, 68 (06) : 1061 - 1069
  • [43] Melphalan-induced apoptosis in multiple myeloma cells is associated with a cleavage of Mcl-1 and Bim and a decrease in the Mcl-1/Bim complex
    Gomez-Bougie, P
    Oliver, L
    Le Gouill, S
    Bataille, R
    Amiot, M
    ONCOGENE, 2005, 24 (54) : 8076 - 8079
  • [44] Mcl-1 Interacts with Akt to Promote Lung Cancer Progression
    Chen, Guo
    Park, Dongkyoo
    Magis, Andrew T.
    Behera, Madhusmita
    Ramalingam, Suresh S.
    Owonikoko, Taofeek K.
    Sica, Gabriel L.
    Ye, Keqiang
    Zhang, Chao
    Chen, Zhengjia
    Curran, Walter J.
    Deng, Xingming
    CANCER RESEARCH, 2019, 79 (24) : 6126 - 6138
  • [45] Melatonin suppresses hepatocellular carcinoma progression via lncRNA-CPS1-IT-mediated HIF-1α inactivation
    Wang, Tong-Hong
    Wu, Chi-Hao
    Yeh, Chau-Ting
    Su, Shih-Chi
    Hsia, Shih-Min
    Liang, Kung-Hao
    Chen, Chin-Chuan
    Hsueh, Chuen
    Chen, Chi-Yuan
    ONCOTARGET, 2017, 8 (47) : 82280 - 82293
  • [46] Puma*Mcl-1 interaction is not sufficient to prevent rapid degradation of Mcl-1
    Yide Mei
    Wenjing Du
    Yonghui Yang
    Mian Wu
    Oncogene, 2005, 24 : 7224 - 7237
  • [47] Melatonin suppresses hepatocellular carcinoma progression via lncRNA-CPS1-IT-mediated HIF-1α inactivation
    Wang, Tong Hong
    Wu, Chi Hao
    Yeh, Chau Ting
    Liang, Kung Hao
    Hsueh, Chuen
    Chen, Chi Yuan
    CANCER RESEARCH, 2017, 77
  • [48] miR-18a-5p suppresses retinal neovascularization by targeting HIF-1α and FGF-1
    Guan, JiTian
    Chi, Zailong
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [49] Targeting MCL-1 protein to treat cancer: opportunities and challenges
    Tantawy, Shady I.
    Timofeeva, Natalia
    Sarkar, Aloke
    Gandhi, Varsha
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [50] Mcl-1 targeting could be an intriguing perspective to cure cancer
    De Blasio, Anna
    Vento, Renza
    Di Fiore, Riccardo
    JOURNAL OF CELLULAR PHYSIOLOGY, 2018, 233 (11) : 8482 - 8498